entertainment -WSS

entertainment

author：hotspot 2025-09-01 15:20:13 - browse：7444

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Antibody drugs appear effective. Now can we make enough of them?

WSS

Sickle cell gene therapy cures need to be accessible in Africa

The strange history of BMI, the body mass index

Grail's uphill battle for Medicare to cover its cancer screening test

One Duchenne patient's bittersweet hope for new treatment

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Vermont grapples with historic flooding as more rainstorms head for Northeast

focus

entertainment

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

23andMe had bad news about my health. I wish a person had delivered it

GOP inquiry over gain

Medical records are filled with copy

One Duchenne patient's bittersweet hope for new treatment

Activists slam private health insurers over coverage restrictions

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ADA: All diabetes patients should be screened for liver condition

hotspot

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Companies helping big Covid

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Watch the official trailer for 'Ahsoka' series

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

explore

hotspot

focus

hotspot